When the company behind the most revolutionary diabetes and weight loss drug in history sheds a staggering $143 billion of its market value in a single day, you’re almost legally obliged to start a column with a gag.
Something about slimming down or crash diets, maybe?
Loading...
James Thomson is senior Chanticleer columnist based in Melbourne. He was the Companies editor and editor of BRW Magazine. Connect with James on Twitter. Email James at j.thomson@afr.com
